Evidence map›Paper›PMID 8657124›Full record

ArticleMolecular and cellular biology1996

Two chimeric receptors of epidermal growth factor receptor and c-Ros that differ in their transmembrane domains have opposite effects on cell growth.

Q Xiong, J L Chan, C S Zong, L H Wang

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. The Impact ofInternational journal of hypertension · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Molecular pathways: ROS1 fusion proteins in cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2013
    Review
  10. Article
  11. Domain-dependent modulation of PDGFRbeta by ganglioside GM1.Journal of molecular neuroscience : MN · 2003
    Article
  12. Oncogenic targeting of an activated tyrosine kinase to the Golgi apparatus in a glioblastoma.Proceedings of the National Academy of Sciences of the United States of America · 2003
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Q XiongDepartment of Microbiology, Mount Sinai School of Medicine, New York, New York 10029, USA.
J L Chan
C S Zong
L H Wang
Icahn School of Medicine at Mount Sinai · US

Funding

TRANSFORMING GENES OF AVIAN SARCOMA VIRUSESR01CA029339 · NCI · ROCKEFELLER UNIVERSITY · PI WANG, LU-HAI · 1985 to 2006
$2.3M
NCI NIH HHS CA29339
6 · The paper itself

Abstract

Two chimeric receptors, ER1 and ER2, were constructed. ER1 contains the extracellular and transmembrane (TM) domains derived from epidermal growth factor receptor and the cytoplasmic domain from c-Ros; ER2 is identical to ER1 except that its TM domain is derived from c-Ros. Both chimeras can be activated by epidermal growth factor and are capable of activating or phosphorylating an array of cellular signaling proteins. Both chimeras promote colony formation in soft agar with about equal efficiency. Surprisingly, ER1 inhibits while ER2 stimulates cell growth on monolayer culture. Cell cycle analysis revealed that all phases, in particular the S and G2/M phases, of the cell cycle in ER1 cells were elongated whereas G1 phase of ER2 cells was shortened threefold. Comparison of signaling pathways mediated by the two chimeras revealed several differences. Several early signaling proteins are activated or phosphorylated to a higher extent in ER1 than in ER2 cells in response to epidermal growth factor. ER1 is less efficiently internalized and remains tyrosine phosphorylated for a longer time than ER2. However, phosphorylation of the 66-kDa She protein, activation of mitogen activated protein kinase, and induction of c-fos and c-jun occur either to a lesser extent or for a shorter time in ER1 cells. Cellular protein phosphorylation patterns are also different in ER1 and ER2 cells. In particular, a 190-kDa Shc-associated protein is tyrosine phosphorylated in ER2 but not in ER1 cells. Our results indicate that the TM domains have a profound effect on the signal transduction and biological activity of those chimeric receptors. The results also imply that sustained stimulation of ER1 due to its retarded internalization apparently triggers an inhibitory response that dominantly counteracts the receptor-mediated mitogenic signals. These two chimeras, expressed at similar levels in the same cell type but having opposite effects on cell growth, provide an ideal system to study the mechanism by which a protein tyrosine kinase inhibits cell growth.

Indexed as

3T3 CellsAnimalsBase SequenceCell DivisionCell MembraneColony-Forming Units AssayErbB ReceptorsKineticsMiceMolecular Sequence DataOligonucleotide ProbesProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesRecombinant Fusion ProteinsErbB ReceptorsOligonucleotide ProbesProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesRecombinant Fusion ProteinsRos1 protein, mouse

Identifiers

PMID8657124
PMCPMC231135
OpenAlexW2154236665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.